Helix BioPharma Corp. announced a private placement financing of 16,655,557 common shares at a price of CAD 0.18 per common share for proceeds of CAD 2,998,000 on August 15, 2023. The common shares issued pursuant are subject to a statutory hold period of four months and one day ending on December 16, 2023, in accordance with applicable securities law.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 CAD | -13.64% | -9.52% | -9.52% |
Apr. 08 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
Mar. 28 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.52% | 36.68M | |
+26.07% | 42.68B | |
-2.64% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.14% | 24.94B | |
-20.82% | 18.96B | |
+29.44% | 12.3B | |
-2.61% | 11.95B | |
-1.14% | 11.55B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it expects to receive CAD 2.998 million in funding